Activities
LAASER activities include:
- HIV drug resistance monitoring: studies in patients that initiate first-line HAART or switch to second-line HAART to monitor the emergence of drug-resistant HIV
- HIV drug resistance surveillance: cross-sectional evaluation of transmission of drug-resistant virus among newly infected patients in geographic settings where HIV treatment is being scaled up
- Development of a laboratory quality assurance program for reference laboratories to help ensure the accuracy and consistency of genotypic resistance analysis undertaken by participating laboratories
- Bringing together civil society stakeholders to join efforts to scale up access to HIV treatment by means of a Roundtable Process